Thymosin A1 - Research Peptide

Thymosin A1 (Tα1) is a 28–amino acid immunomodulatory peptide, studied for its role in supporting T-cell maturation and enhancing innate and adaptive immune responses. It has been investigated for its effects on cytokine balance and Toll-like receptor signaling. New Wave Peptides supplies Thymosin A1 in 10MG vials, lab-tested and verified for purity, strictly for scientific use in controlled environments.

Download Third Party COA: Thymosin A1 COA - Batch 19950
This batch (19950) is independently tested by Janoshik and confirmed to exceed 99% purity. Each vial is batch-labelled for traceability and consistent research standards.

• Batch Number: 19950
• Molecular Formula: C129H215N33O55
• Peptide Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
• Peptide Type: Immunomodulatory Peptide
• Research Only: Yes
• Purity: 99.740%
• Heavy Metals Report: See Report
• Endotoxin Test: See report
• Form: Lyophilised Solid
• Mixing Water Required: Yes

Usage and Storage:

Thymosin A1 is supplied as a lyophilised powder to maximise shelf life and stability. Store in a cool, dry place. After reconstitution with sterile or bacteriostatic water, refrigerate and use within the recommended timeframe.

Peptide Mixing Notes

Allow both the vial and the mixing solution to reach room temperature before reconstitution. Gently swirl the vial—do not shake—to preserve peptide integrity and effectiveness.

⚠️ Research Use Only – Important Legal Notice

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation,
• Supplied to another party for human investigational use.